Articles by José R Arribas, MD

A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected...

Martínez, Esteban; Arranz, José A; Podzamczer, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(3):290-297, July 2009.

Lipid and Apoprotein Profile in HIV-1-Infected Patients After CD4-Guided Treatment Interruption

Seoane, Elena; Resino, Salvador; Micheloud, Dariela; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(4):455-459, August 1st, 2008.

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression: 48-Week Results of a Randomized, Controlled, Open-Label, Proof-of-Concept Pilot Clinical...

Arribas, José R; Pulido, Federico; Delgado, Rafael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):280-287, November 1st, 2005.